ADVOCATE. CONNECT. INNOVATE.

LIfe Sciences Roundtable

Burlingame, California

7/25/2018

12:00pm - 6:00pm

Please join us for the 3rd Annual Bay Area Lifesciences Roundtable — an afternoon of interactive discussions addressing cutting-edge trends and hot topics in the lifesciences industry.

Who should attend?
Executives, Investors, General Counsel and Company Counsel

Agenda
12:00 p.m. to 1:00 p.m. Registration and Networking Lunch
1:00 p.m. to 4:00 p.m. Program
4:00 p.m. to 5:00 p.m. Keynote Speaker – Dr. Matthew Walker
Cocktail Reception to Follow

YOU ARE INVITED
Wednesday, July 25, 2018
Hyatt Regency - San Francisco Airport
Please join us for the 3rd Annual Bay Area Lifesciences Roundtable — an afternoon of interactive discussions addressing cutting-edge trends and hot topics in the lifesciences industry.
Who should attend?
Executives, Investors, General Counsel and Company Counsel

Panel Information
Collaborations: One Size Does NOT Fit All
• Conditions for successful collaborations
• The shift in how companies approach strategic collaborations
• Where are we succeeding and where do the models fall short
• Structural trends and changes to maximize successful partnerships

Panelists:
Alice Hsieh, Sr. Counsel Specialist, Assistant General Counsel, Genentech;
Debanjan Ray, Chief Financial Officer and Head of Corporate Development, CytomX Therapeutics, Inc.; Mark Wilson, Senior Vice President and General Counsel, Nektar Therapeutics; Josh Hofheimer Partner, Sidley Austin LLP

Lifesciences in the Fast Lane: New Approaches to Bringing MedTech and Drugs to Market Faster

• A conversation with Bakul Patel on FDA's Pre-Certification Program for Digital Health Products
• Approaches to data analytics that drive success in drug trials
• Uses of real world evidence to support expanded indications

Panelists:
Bakul Patel, Associate Center Director for Digital Health, U.S. Food and Drug Administration; Dennis Fisher, MD, President, P Less Than; Professor (Emeritus), Department of Anesthesia, University of California, San Francisco; Scott Bass, Partner, Sidley Austin LLP; Nancy Stade, Partner, Sidley Austin LLP

Conundrum of Navigating the EU Legal Framework: What Are the New Developments?
• Brexit Update: What does Brexit mean for lifesciences companies?
• Data Privacy: Taking stock of GDPR
• IP Update: What’s at stake with IP regulatory rights review?
• Compliance: Evaluating the evolving EU compliance framework
• Tightening Competition Controls: From patent settlement to off-label prescribing, what are the EU competition authorities claiming the pharmaceutical industry is doing wrong?

Panelists:
Virginia MacSuibhne, Vice President, Chief Compliance Officer, Roche Molecular Solutions; Marie Manley, Partner, Sidley Austin LLP; Wim Nauwelaerts, Partner, Sidley Austin LLP; Michele Tagliaferri, Partner, Sidley Austin LLP

Keynote Speaker
Dr. Matthew Walker is the author of the New York Times bestseller, Why We Sleep, which was recently selected for the prestigious Sundance Book Festival. Why We Sleep has a singular goal: to reunite humanity with sleep. Dr. Walker holds numerous U.S. patents concerning consumer-based sleep recording, sleep tracking and sleep stimulation, as well as several patents focused on the commercial use of consumer-based sleep measures as they apply to health, technology, business and enterprise.
Dr. Walker is a former Professor of Psychiatry at Harvard Medical School, and currently is Professor of Neuroscience and Psychology at the University of California, Berkeley, where he is also the founder and director of the Center for Human Sleep Science.

Agenda
12:00 p.m. to 1:00 p.m. Registration and Networking Lunch
1:00 p.m. to 4:00 p.m. Program
4:00 p.m. to 5:00 p.m. Keynote Speaker – Dr. Matthew Walker
Cocktail Reception to Follow


For more information, contact sfevents@sidley.com.

Sidley Austin LLP is an accredited MCLE provider in CA, NY and IL. CLE credit for this program is pending.

Click Here for More Information

Contact: Alon Sugarman
Contact Phone: +1 415 772 7426
Contact Email: asugarman@sidley.com